Annual Total Liabilities
$145.87 M
-$2.03 M-1.37%
31 December 2023
Summary:
Rigel Pharmaceuticals annual total liabilities is currently $145.87 million, with the most recent change of -$2.03 million (-1.37%) on 31 December 2023. During the last 3 years, it has risen by +$69.52 million (+91.05%). RIGL annual total liabilities is now -1.37% below its all-time high of $147.90 million, reached on 31 December 2022.RIGL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$154.06 M
-$4.27 M-2.70%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly total liabilities is currently $154.06 million, with the most recent change of -$4.27 million (-2.70%) on 30 September 2024. Over the past year, it has increased by +$6.90 million (+4.69%). RIGL quarterly total liabilities is now -2.70% below its all-time high of $158.32 million, reached on 30 June 2024.RIGL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.4% | +4.7% |
| 3 y3 years | +91.0% | +12.6% |
| 5 y5 years | +399.0% | +76.8% |
RIGL Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.4% | +91.0% | -2.7% | +17.0% |
| 5 y | 5 years | -1.4% | +399.0% | -2.7% | +137.5% |
| alltime | all time | -1.4% | +856.4% | -2.7% | +1011.2% |
Rigel Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $154.06 M(-2.7%) |
| June 2024 | - | $158.32 M(+0.1%) |
| Mar 2024 | - | $158.19 M(+8.4%) |
| Dec 2023 | $145.87 M(-1.4%) | $145.87 M(-0.9%) |
| Sept 2023 | - | $147.16 M(+1.3%) |
| June 2023 | - | $145.21 M(-1.8%) |
| Mar 2023 | - | $147.87 M(-0.0%) |
| Dec 2022 | $147.90 M(+8.0%) | $147.90 M(+9.2%) |
| Sept 2022 | - | $135.44 M(+2.9%) |
| June 2022 | - | $131.68 M(-7.4%) |
| Mar 2022 | - | $142.28 M(+3.9%) |
| Dec 2021 | $136.95 M(+79.4%) | $136.95 M(+0.1%) |
| Sept 2021 | - | $136.85 M(+2.5%) |
| June 2021 | - | $133.49 M(-3.1%) |
| Mar 2021 | - | $137.69 M(+80.3%) |
| Dec 2020 | $76.35 M(-18.6%) | $76.35 M(+5.9%) |
| Sept 2020 | - | $72.10 M(-3.6%) |
| June 2020 | - | $74.83 M(+15.4%) |
| Mar 2020 | - | $64.86 M(-30.8%) |
| Dec 2019 | $93.75 M(+220.7%) | $93.75 M(+7.6%) |
| Sept 2019 | - | $87.15 M(+11.9%) |
| June 2019 | - | $77.87 M(+0.5%) |
| Mar 2019 | - | $77.47 M(+165.0%) |
| Dec 2018 | $29.23 M(+58.3%) | $29.23 M(+48.4%) |
| Sept 2018 | - | $19.70 M(+11.6%) |
| June 2018 | - | $17.65 M(-7.1%) |
| Mar 2018 | - | $19.01 M(+2.9%) |
| Dec 2017 | $18.46 M(-20.1%) | $18.46 M(+22.4%) |
| Sept 2017 | - | $15.08 M(-5.0%) |
| June 2017 | - | $15.87 M(-8.0%) |
| Mar 2017 | - | $17.25 M(-25.4%) |
| Dec 2016 | $23.11 M(-42.8%) | $23.11 M(+1.8%) |
| Sept 2016 | - | $22.70 M(-11.3%) |
| June 2016 | - | $25.60 M(-22.0%) |
| Mar 2016 | - | $32.83 M(-18.7%) |
| Dec 2015 | $40.37 M(+55.9%) | $40.37 M(-5.6%) |
| Sept 2015 | - | $42.76 M(-9.4%) |
| June 2015 | - | $47.20 M(-11.8%) |
| Mar 2015 | - | $53.54 M(+106.8%) |
| Dec 2014 | $25.89 M(+45.4%) | $25.89 M(+58.2%) |
| Sept 2014 | - | $16.37 M(-2.0%) |
| June 2014 | - | $16.70 M(+11.6%) |
| Mar 2014 | - | $14.96 M(-16.0%) |
| Dec 2013 | $17.81 M(-15.0%) | $17.81 M(+10.4%) |
| Sept 2013 | - | $16.14 M(-2.9%) |
| June 2013 | - | $16.62 M(-5.7%) |
| Mar 2013 | - | $17.63 M(-15.8%) |
| Dec 2012 | $20.95 M | $20.95 M(+7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $19.51 M(+4.8%) |
| June 2012 | - | $18.61 M(+7.4%) |
| Mar 2012 | - | $17.33 M(-17.3%) |
| Dec 2011 | $20.96 M(+1.9%) | $20.96 M(+17.1%) |
| Sept 2011 | - | $17.90 M(+4.2%) |
| June 2011 | - | $17.18 M(+5.0%) |
| Mar 2011 | - | $16.36 M(-20.5%) |
| Dec 2010 | $20.56 M(-33.4%) | $20.56 M(-71.2%) |
| June 2010 | - | $71.48 M(-42.5%) |
| Mar 2010 | - | $124.36 M(+302.8%) |
| Dec 2009 | $30.88 M(-22.2%) | $30.88 M(-9.2%) |
| Sept 2009 | - | $33.99 M(-7.3%) |
| June 2009 | - | $36.67 M(-1.1%) |
| Mar 2009 | - | $37.06 M(-6.6%) |
| Dec 2008 | $39.69 M(+18.1%) | $39.69 M(+4.9%) |
| Sept 2008 | - | $37.84 M(+16.5%) |
| June 2008 | - | $32.47 M(+14.3%) |
| Mar 2008 | - | $28.42 M(-15.4%) |
| Dec 2007 | $33.61 M(+29.2%) | $33.61 M(+32.5%) |
| Sept 2007 | - | $25.36 M(+6.1%) |
| June 2007 | - | $23.90 M(-2.9%) |
| Mar 2007 | - | $24.62 M(-5.3%) |
| Dec 2006 | $26.01 M(-33.4%) | $26.01 M(+4.3%) |
| Sept 2006 | - | $24.94 M(-3.8%) |
| June 2006 | - | $25.93 M(-25.2%) |
| Mar 2006 | - | $34.68 M(-11.3%) |
| Dec 2005 | $39.08 M(+47.4%) | $39.08 M(+21.6%) |
| Sept 2005 | - | $32.14 M(-6.8%) |
| June 2005 | - | $34.47 M(-3.1%) |
| Mar 2005 | - | $35.59 M(+34.2%) |
| Dec 2004 | $26.52 M(+70.5%) | $26.52 M(+43.3%) |
| Sept 2004 | - | $18.51 M(+8.7%) |
| June 2004 | - | $17.03 M(+7.4%) |
| Mar 2004 | - | $15.86 M(+2.0%) |
| Dec 2003 | $15.55 M(-17.7%) | $15.55 M(-1.3%) |
| Sept 2003 | - | $15.76 M(+5.0%) |
| June 2003 | - | $15.00 M(-1.3%) |
| Mar 2003 | - | $15.19 M(-19.6%) |
| Dec 2002 | $18.90 M(+8.0%) | $18.90 M(-10.9%) |
| Sept 2002 | - | $21.21 M(-1.3%) |
| June 2002 | - | $21.49 M(-2.0%) |
| Mar 2002 | - | $21.93 M(+25.3%) |
| Dec 2001 | $17.51 M(+14.8%) | $17.51 M(-5.7%) |
| Sept 2001 | - | $18.57 M(+33.9%) |
| June 2001 | - | $13.86 M(-4.7%) |
| Mar 2001 | - | $14.54 M(-4.7%) |
| Dec 2000 | $15.25 M(-7.1%) | $15.25 M |
| Dec 1999 | $16.41 M | - |
FAQ
- What is Rigel Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual total liabilities year-on-year change?
- What is Rigel Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly total liabilities year-on-year change?
What is Rigel Pharmaceuticals annual total liabilities?
The current annual total liabilities of RIGL is $145.87 M
What is the all time high annual total liabilities for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual total liabilities is $147.90 M
What is Rigel Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, RIGL annual total liabilities has changed by -$2.03 M (-1.37%)
What is Rigel Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of RIGL is $154.06 M
What is the all time high quarterly total liabilities for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly total liabilities is $158.32 M
What is Rigel Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, RIGL quarterly total liabilities has changed by +$6.90 M (+4.69%)